Evidence map›Paper›PMID 30080036›Full record

ArticleACS nano2018

A Robust Liposomal Platform for Direct Colorimetric Detection of Sphingomyelinase Enzyme and Inhibitors.

Margaret N Holme, Subinoy Rana, Hanna M G Barriga, Ulrike Kauscher, Nicholas J Brooks, Molly M Stevens

Open access · hybridAbstract read
In one paragraph

Article in ACS nano, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Nanomaterials-Based Colorimetric Immunoassays.Nanomaterials (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Margaret N HolmeDepartment of Materials , Imperial College London , London , SW7 2AZ , U.K.ORCID 0000-0002-7314-9493
Subinoy RanaDepartment of Materials , Imperial College London , London , SW7 2AZ , U.K.ORCID 0000-0002-8039-1149
Hanna M G BarrigaDepartment of Medical Biochemistry and Biophysics , Karolinska Institutet , SE-171 77 Stockholm , Sweden.ORCID 0000-0002-2530-5332
Ulrike KauscherDepartment of Materials , Imperial College London , London , SW7 2AZ , U.K.
Nicholas J BrooksDepartment of Chemistry , Imperial College London , London , SW7 2AZ , U.K.ORCID 0000-0002-1346-9559
Molly M StevensDepartment of Materials , Imperial College London , London , SW7 2AZ , U.K.ORCID 0000-0002-7335-266X
Imperial College London · GBKarolinska Institutet · SE

Funding

European Research Council 616417
6 · The paper itself

Abstract

The enzyme sphingomyelinase (SMase) is an important biomarker for several diseases such as Niemann Pick's, atherosclerosis, multiple sclerosis, and HIV. We present a two-component colorimetric SMase activity assay that is more sensitive and much faster than currently available commercial assays. Herein, SMase-triggered release of cysteine from a sphingomyelin (SM)-based liposome formulation with 60 mol % cholesterol causes gold nanoparticle (AuNP) aggregation, enabling colorimetric detection of SMase activities as low as 0.02 mU/mL, corresponding to 1.4 pM concentration. While the lipid composition offers a stable, nonleaky liposome platform with minimal background signal, high specificity toward SMase avoids cross-reactivity of other similar phospholipases. Notably, use of an SM-based liposome formulation accurately mimics the natural in vivo substrate: the cell membrane. We studied the physical rearrangement process of the lipid membrane during SMase-mediated hydrolysis of SM to ceramide using small- and wide-angle X-ray scattering. A change in lipid phase from a liquid to gel state bilayer with increasing concentration of ceramide accounts for the observed increase in membrane permeability and consequent release of encapsulated cysteine. We further demonstrated the effectiveness of the sensor in colorimetric screening of small-molecule drug candidates, paving the way for the identification of novel SMase inhibitors in minutes. Taken together, the simplicity, speed, sensitivity, and naked-eye readout of this assay offer huge potential in point-of-care diagnostics and high-throughput drug screening.

Indexed as

ColorimetryAnimalsBiphenyl CompoundsCattleDesipramineEnzyme InhibitorsLiposomesMolecular StructureNaphthalenesParticle SizePyrimidinonesSphingomyelin PhosphodiesteraseSurface PropertiesaltenusinBiphenyl CompoundscambinolDesipramineEnzyme InhibitorsLiposomesNaphthalenesPyrimidinonesSphingomyelin Phosphodiesterasecholesterolcolorimetric detectiongold nanoparticleliposomesphingomyelinsphingomyelinase

Identifiers

PMID30080036
PMCPMC6117748
OpenAlexW2887716619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.